Contact

Please use this form to send email to PR contact of this press release:
Primo Biotech and Anbogen Therapeutics Forge Co-Develop Precision Radioligand for Solid Tumors Diagnosis and Therapy

TO:
Sunny Chen
Primo Biotechnology Co, Ltd.
+886 919 350 725

FROM:
Your Name:
Your Email:	Please check your email address!
Subject:
Message:
Confirmation code:	Please, do not fill this field.
Confirmation version code:	Please, do not change this field.
Javascript data:	Please, do not fill if your javascript is turned off.
Please type in the code you see in the image. Or click Send Email to generate another image instead.
	SEND EMAIL